إعلان مُمول
Dr Reddy's receives two USFDA observations for New York API facility
نشر بتاريخ
Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.
البحث
الأقسام
- National
- International
- Business
- Technology
- Health
- التعليم
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
إقرأ المزيد
Severe weather, including possible tornado, leaves at least 14 dead in Kentucky; 7 dead in Missouri
Severe storms ravaged the Midwest and South, resulting in at least 21 fatalities. Kentucky...
Palak on Pak critic's comment on Ibrahim's nose
Ibrahim Ali Khan faced criticism for his Bollywood debut in Nadaaniyan, including a personal...